Evgen is a UK-based biopharmaceutical company that is taking a novel approach to developing a new anti-cancer drug. The active component is sulforaphane which has its effects through modulating multiple cancer-related pathways in the body. However sulforaphane on its own is very unstable so Evgen are developing ways to address this.

Evgen Pharma needed a visual tool to help explain its technology to investors and other stakeholders.